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Abstract
Background: Voltage-dependent K
+ channels (Kv) mediate repolarisation of b-cell action potentials, and thereby abrogate
insulin secretion. The role of the Kv1.1 K
+ channel in this process is however unclear. We tested for presence of Kv1.1 in
different species and tested for a functional role of Kv1.1 by assessing pancreatic islet function in BALB/cByJ (wild-type) and
megencephaly (mceph/mceph) mice, the latter having a deletion in the Kv1.1 gene.
Methodology/Principal Findings: Kv1.1 expression was detected in islets from wild-type mice, SD rats and humans, and
expression of truncated Kv1.1 was detected in mceph/mceph islets. Full-length Kv1.1 protein was present in islets from wild-
type mice, but, as expected, not in those from mceph/mceph mice. Kv1.1 expression was localized to the b-cell population
and also to a- and d-cells, with evidence of over-expression of truncated Kv1.1 in mceph/mceph islets. Blood glucose, insulin
content, and islet morphology were normal in mceph/mceph mice, but glucose-induced insulin release from batch-
incubated islets was (moderately) higher than that from wild-type islets. Reciprocal blocking of Kv1.1 by dendrotoxin-K
increased insulin secretion from wild-type but not mceph/mceph islets. Glucose-induced action potential duration, as well as
firing frequency, was increased in mceph/mceph mouse b-cells. This duration effect on action potential in b-cells from
mceph/mceph mice was mimicked by dendrotoxin-K in b-cells from wild-type mice. Observations concerning the effects of
both the mceph mutation, and of dendrotoxin-K, on glucose-induced insulin release were confirmed in pancreatic islets
from Kv1.1 null mice.
Conclusion/Significance: Kv1.1 channels are expressed in the b-cells of several species, and these channels can influence
glucose-stimulated insulin release.
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Introduction
It is established that voltage-dependent K
+ channels (Kv)
mediate repolarisation of b- cell action potential and thereby
abrogate insulin secretion. Elucidation of the molecular mecha-
nisms and the regulation of Kv channels are however complicated
by their multitude of forms, each class being recognized to have
several subcategories. Alpha subunits form the actual conductance
pore and have been grouped into 12 classes named Kv1-12.
Among these channels, Kv2.1 has been shown to be robustly
functional in b-cells, to the extent that in a number of species, it is
regarded as the most influential Kv channel on insulin secretion
[1]. A considerable impact of this channel at the level of
electrophysiology has also been documented [2].
It is also recognized that Kv2.1 is not the only Kv channel of
importance [2]. Kv1.1 has in animal models been found to be
functional in brain, gastrointestinal muscle cells, renal tissue and
heart [3, 4, 5]. A functional role for the Kv1.1 channel in b-cells
has been questioned and its expression in this tissue has not been
consistently detected [6]. However, a systematic search for the
Kv.1.1 channels has not been performed, and a role for Kv1.1 in
b-cell function and/or development has not, to our knowledge,
been tested rigorously.
In this study, we first obtained preliminary results showing
that isolated islets of Langerhans from BALB/cByJ-Kv1.1
mceph/mceph
mice (called mceph/mceph), for which the Kv1.1 protein is truncated
and non-functional secreted more insulin than islets from wild
type mice to a glucose challenge. We then searched for and
found evidence for Kv1.1 expression in islets from several strains
of mice as well as in islets from rats and humans. We continued
to test for functional and developmental effects of Kv1.1 on
b-cells. We found, as expected that a full-length Kv1.1 protein
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evidence for mutation-linked effects on insulin secretion we
performed electrophysiological measurements to test for traits
associated with Kv channel deficiency. Finally, analyses of mice
in which the Kv1.1 gene was knocked out (BALB/cByJ.C3
HeB/FeJ-Kv1.1
2/2) confirmed some of the key results in this
study.
Materials and Methods
Ethics statement
All animal studies were approved by the Northern Stockholm
Ethical Committee on Experimental Animal Care (376/03; 348/
06) and performed in accordance with guidelines from the Swedish
National Board for Laboratory Animals. Human islets were
obtained from a Nordic network under conditions specified
elsewhere [7].
Reverse-transcription polymerase chain reaction (PCR)
Total RNA was isolated using RNeasy kits, reverse transcribed
and analyzed by conventional and real-time PCR as described in
Supporting Information.
Microarray
Human islets were obtained from three normal individuals and
cultured for 48 h in 5.5 mmol/l glucose before RNA was isolated.
Labelled cRNAs were synthesized and hybridised to the Human
Gene 1.0 ST Array (Affymetrix, Santa Clara, CA) at the Novum
Affymetrix core facility, Karolinska Institutet.
mceph/mceph and Kv1.1 null mice
The BALB/cByJ-Kv1.1
mceph/mceph mouse (called mceph/mceph, [8]
displays temporal lobe epilepsy from a deletion in Kv1.1 resulting
in the expression of a truncated Kv1.1 protein (MCEPH) retaining
only the cytosolic N-terminal region, the first transmembrane
segment and the first extracellular loop, whilst the voltage sensor
and the ion pore domains are lost [9,10,11]. In the normal brain,
Kv1.1 forms tetramers with other Kv1 subunits via the N-terminal
and first transmembrane domain [12], creating channels that
regulate neuronal excitability and signalling [13]. Kv1.1 null mice
on BALB/cByJ background show an epileptic behaviour similar to
mceph/mceph mice [14].
The inbred strains BALB/cByJ-Kv1.1
mceph/mceph BALB/cByJ-
Kv1.1
+/+ and C3HeB/FeJ-Kcna1
tm1Tem were originally obtained
from The Jackson Laboratory, Bar Harbor, ME). Fully congenic
BALB/cByJ.C3HeB/FeJ-Kv1.1
2/2 (Kv1.1 null) mice were gener-
ated at Karolinska Institutet. Briefly, C3HeB/FeJ-Kcna1
tm1Tem mice
were outcrossed to BALB/cByJ-Kv1.1
+/+. F1 males/females
heterozygous for the Kv1.1 null locus were backcrossed to the
recipient strain BALB/cByJ-Kv1.1
+/+ for 10 generations; where
after heterozygous mating generated homozygous null mice.
Histopathological and immunohistochemical techniques
Pancreatic glands were dissected away from the surrounding
tissues in their entirety. Specimens from the corpus/cauda regions
were used for histopathological staining procedures and immuno-
histochemical (IHC) analyses. For further details see Supporting
Information.
Western blotting
Protein extracts were separated on SDS-PAGE gels, transferred
to nitrocellulose filters and probed with monoclonal antibodies as
described in Supporting Information.
Blood collection and isolation and culture of pancreatic
islets
Blood collection and isolation of pancreatic islets as well as tissue
culture of MIN6 and INS-1 cells, were carried out as described in
Supporting Information.
Insulin release measurements
Batch–type incubations. Following culture and
preincubation as described in Supporting Information equal sized
islets were incubated in groups of three for 60 min at 37uCi n3 0 0ml
KRB containing 3.3 or 16.7 mmol/l glucose, each with or without
10 nM dendrotoxin-K. Each experimental condition consisted of
three or four individual groups of three islets. The insulin
accumulated in the incubation medium was measured as previously
described [15]. Islet insulin content was measured after acid-ethanol
extraction [16] of islets retrieved from the batch incubations.
Perifusion of islets and dispersed islet cells. After culture
and preincubation, 60–80 islets or dispersed islet cells from the
same amount of islets (see Supporting information) were added to
each of two or three perifusion chambers and perifused as
previously described [17]. Briefly, islets or cell suspension were
layered between polystyrene beads (Bio-Rad) and perifused by use
of a peristaltic pump (Ismatec SA, Zu ¨rich, Switzerland). Samples
of the perifusate were collected every minute, frozen and stored at
220uC.
Fura-2 imaging
Fura-2 imaging of dispersed islet cells was performed with a
camera (CH250/KAF1400, Photometrics, Tucson, AZ, USA)
coupled to an inovison imaging system (Durham, NC, USA) using
an inverted fluorescence microscope (Axiovert135TV, Zeiss,
Go ¨ttingen, Germany). For details see Supporting Information.
Electrophysiology
Whole-cell currents and membrane potentials were recorded
with patch-clamp technique [18] by using an EPC-10 patch-clamp
amplifier (HEKA Electronics, Lambercht, Germany). All exper-
iments were performed at room temperature, approximately
22uC. For details see Supporting Information.
Statistical analysis
Results are expressed as mean 6 SEM. Significant differences
in the means of sample groups from mceph/mceph and wild-type
mice were tested using Student’s paired t- test (two-sided). A P
value ,0.05 was considered significant.
Results
Detection of Kv1.1 mRNA expression
We demonstrated Kv1.1-specific expression using cDNA from
wild-type and BALB/cByJ-Kv1.1
mceph/mceph mice (mceph/mceph), for
which the Kv1.1 protein is truncated and non-functional (Fig. 1A).
One of the amplicons employed covered the mceph mutation and
accordingly differed in size between mceph/mceph and wild-type
islets (Fig. 1B).
We detected Kv1.1 expression both in islets from ob/ob and lean
mice, as well as in islets from rat (Fig. 1C). Kv1.1 expression was
also detected in the INS-1 cell line, but not in MIN6 cells (Fig. 1C).
Importantly we in addition detected Kv1.1 expression in human
islets isolated from both non-diabetic donors and donors with type
2 diabetes (Fig. 1D). Using real-time PCR no differences in Kv1.1
expression levels (relative to 18S) were observed between islets
from three non-diabetic and three diabetic individuals. However,
Kv1.1 Channels in b-Cells
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in islets from donors with type 2 diabetes (1.060.05 vs. 1.560.8,
P=0.7, n=3, Fig. 1E).
Kv1.1 expression was also verified in human islets from three
non-diabetic individuals by microarray (Affymetrix, results not
shown).
Hence, Kv1.1 expression was detectable in normal islet tissue
from rats, humans and mice.
Detection of Kv1.1 protein
By Western blotting using a monoclonal antibody against the C-
terminal of Kv1.1 protein, the full-size Kv1.1 protein was demon-
strated to be present in islets from w i l d - t y p em i c ea n dr a t s( F i g .2 A ) ,
but, as expected, could not be detected in islets from mceph/mceph mice
which express only the N-terminal of Kv1.1 protein (Fig. 2A).
To investigate in which islet cell types the Kv1.1 protein was
present we performed double immunostaining for Kv1.1 and
insulin, as well as for glucagon and somatostatin. The Kv1.1
antibody used was against the N-terminal region present in both
the normal and the truncated proteins. A clear-cut Kv1.1-like
immunoreactivity was found to be co-localized with insulin in the
b- cells both in wild-type and in mceph/mceph mice. The
immunoreactivity was moderate in islets of wild-type mice
(Fig. 2B, upper panel, green), but strong in islets of mutated
mceph/mceph mice (Fig. 2B, lower panel). Hence, the IHC data
suggest over-expression of the truncated protein in mceph/mceph
islets.
We also found co-localization of Kv1.1 with glucagon in the a-
cells as well as with somatostatin in d-cells (data not shown).
The peptide, used to generate the N-terminal Kv1.1 antibody,
shares an identity with Kv1.2 consisting of a stretch of 6 out of 24
amino acids. No signal was elicited when islets from mceph/mceph
mice were incubated with an antibody against Kv1.2. This
observation indicates that the signal elicited by the Kv1.1 antibody
was due to the truncated (over-expressed) Kv1.1 protein and not
due to cross-reactivity with Kv1.2 (Fig. 2C).
Islet structure in mceph/mceph mice
The basic structure of the pancreatic islets of Langerhans was
similar for mutant, and wild-type mice, as detected using histopath-
Figure 1. Kv1.1 is expressed in mceph/mceph mice. Kv1.1 mRNA expression in islets from wild-type and mceph/mceph mice by RT-PCR with the
S2645-AS3455 (A) and S2688-AS2912 (B) primer pairs, which amplify sequences not including, and including, the mceph mutation respectively.
Marker=pUC18 Msp I digest. Kv1.1 is expressed in mice, rat and human islets as well as INS-1 cells but not MIN6 cells. Kv1.1 mRNA
expression by RT-PCR with the S2645-AS3455 primer pair (C). Marker=pUC18 Msp I digest. (D) Kv1.1 mRNA expression in islets isolated from three
human control and three diabetic individuals by RT-PCR with the S1926-AS2092 primer pair. Marker=pUC18 MspI digest. (E) Kv1.1 mRNA expression
levels relative to 18S RNA by real-time PCR in islets from human non-diabetic (n=3) and diabetic individuals (n=3). Samples were run in duplicates.
All analyses included a corresponding negative control (RT-ve).
doi:10.1371/journal.pone.0018213.g001
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structure of rodent islets was seen, with insulin-immunoreactive cells
predominating in the central areas of islets, and glucagon- and
somatostatin- imunoreactive cells at the periphery. The proportions
of these cell types were 85% insulin-imunoreactive cells, 10%
glucagon-imunoreactive cells, and 5% somatostatin- imunoreactive
cells (Fig. 3A). There was no evidence of necrosis, inflammation,
hypertrophy or atrophy of the three islet parenchymal cell types.
Detection of Kv 2.1 protein
Over-expression of truncated Kv.1.1 protein in the mceph/mceph
could affect other Kv channels. To investigate that we performed
Western blot for the most important Kv channel involved in
repolarisation of action potentials in the beta cell, namely Kv 2.1.
No sign of change in the expression of Kv 2.1 channel protein was
seen in mceph/mceph vs. wild type islets (108610 vs. 100%, n=3,
Fig. 3B+C).
Figure 2. Kv1.1 protein is present in islets from wild type mice and rats. Western blotting using a monoclonal antibody against the C-
terminal of Kv1.1 protein (A). Brain from wild type and mceph/mceph mice was used as controls. mceph/mceph served as specificity control as these
mice express only the N-terminal of Kv1.1. b-actin was used as loading control. Kv1.1 protein is present in b-cells. Islets from wild type mice (wt)
(B upper panel) and mceph/mceph (m/m) mice (B lower panel) double immunostained for N-terminal Kv1.1 (green, left) and insulin (red, middle);
merged to the right. The N-terminal of Kv1.1 is present in beta cells of both genotypes. Note that Kv1.1 is up-regulated in mceph/mceph mice
compared to wild type mice. Specificity of the N-terminal Kv1.1-LI was tested by determining the level of Kv1.2-LI. Strong N-terminal Kv1.1-LI and very
weak Kv1.2-LI in an islet from mceph/mceph mice assured that the Kv1.1-LI reflected presence of Kv1.1 (C).
doi:10.1371/journal.pone.0018213.g002
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Body weights were lower in mceph/mceph vs. wild-type mice at
corresponding ages (Table 1). Levels of blood glucose (non-fasting)
did not differ between mceph/mceph and wild-type mice (Table 1).
Islet insulin contents and secretion
Insulin contents of isolated islets did not differ between mceph/
mceph and wild-type islets (16566194 vs.15096111 mU/islet,
n=11).
Figure 3. Normal islet structure in mceph/mceph and Kv 1.1 null mice compared to wild type mice. Medium-power photomicrographs,
showing- all at the same magnification x400-serial sections of an islet of Langerhans in the pancreatic parenchyma from mice belonging to the three
strains (A). The fact that the islet chosen for this particular set of photomicrographs happens to be larger from the Kv1.1 null mouse strain than those
from the other two strains, is by pure incidence only, and does not, by no means, imply that the Kv1.1 null islets in general would be larger than those
in a normal murine pancreas. Over-expression of truncated Kv1.1 protein in mceph/mceph does not affect the expression of Kv2.1
protein. Western blot with a polyclonal antibody against Kv2.1 protein in islets from mceph/mceph. Column diagram shows compiled data from 3
individual experiments (C), blots are from a typical experiment (B).
doi:10.1371/journal.pone.0018213.g003
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amounts of insulin during culture conditions (596658 vs.
588663 mU/islet/24 h). In batch incubations however, glucose
(16.7 mmol/l) -induced insulin secretion was moderately although
significantly enhanced in islets from mceph/mceph mice (7169.5 vs.
5267.5 mU/islet/h, respectively, P,0.03, n=11, Fig. 4A). We
also performed experiments in the presence of the Kv1.1-specific
blocker dendrotoxin-K [19]. Addition of dendrotoxin-K to 16.7
mmol/l glucose-containing media tended to increase insulin
secretion from wild type islets (from 4969.6 to 68614 mU/islet/
h), whereas there was a decrease in release from mceph/mceph islets
(from 60613 to 50610 mU/islet/h, n=7, Fig. 4B). The difference
in response to dendrotoxin-K in wild-type and mceph/mceph mice
was significant, P=0.02 (Fig 4C).
Perifusion experiments
Islets from wild type and mceph/mceph mice were perifused with
3.3 mmol/l glucose followed by 16.7 mmol/l glucose and finally
10 nmol/l dendrotoxin-K was added to the 16.7 mmol/l glucose
in one perifusion chamber whereas the other chamber continued
to be perifused with 16.7 mmol/l glucose only. The response to
dendrotoxin-K was calculated as follows: The average insulin
response to 16.7 mmol/l glucose was calculated for min 29–49
and subtracted from the average insulin response at min 69–89
making it possible to calculate the pure effect of dendrotoxin-K in
each channel. In wild type islets dendrotoxin-K elicited a
significant insulin response of 0.2960.1 mU/islet/min, P=0.05,
Fig. 4D and G) whereas no such response was seen in islets from
mceph/mcpeh mice (20.160.1 mU/islet/min, P=0.45, Fig. 4E and
G). The difference in response between the strains was significant
(P=0.035). Also the insulin response to elevating glucose from 3.3
to 16.7 mmol/l during perifusion was significantly increased in
islets from mceph/mceph vs. wild-type mice (0.3460.04 vs.
0.5160.04 mU/islet/min, P=0.01, Fig. 4D, E and G).
We also performed experiments in dispersed islet cells from wild
type mice (Fig. 4H). In these experiments basal insulin secretion
was similar before stimulation with dendrotoxin-K and TEA
(Tetraethylammonium, a non-selective K
+ channel inhibitor). In
the presence of 16.7 mmol/l glucose TEA increased insulin
secretion by 148664%, n=3, Fig. 4H. A much smaller but still
significant effect was obtained by the addition of dendrotoxin-K
which increased insulin secretion by 3569%, P, 0.04.
Fura-2 imaging
We measured [Ca
2+]i responses to 15 mmol/l glucose 6
dendrotoxin-K in dispersed islet cells from mceph/mceph (n=10)
and wild type mice (n=8) using fura-2 imaging. We did not detect
any differences between wild type and mceph/mceph, (results not
shown).
Electrophysiology
Previous studies in brain tissue found that electrophysiological
parameters were affected by the mceph/mceph mutation [10].
Furthermore, other Kv deficiencies give rise to excitatory
abnormalities in b-cells [2]. Our aim was to see if abnormalities
indicative of Kv channel deficiencies and specifically those of
Kv1.1, were present in mceph/mceph islets.
Whole-cell currents. Whole-cell currents were recorded
from pancreatic b-cells isolated from wild-type and mceph/mceph
mice, using the whole-cell configuration of the patch-clamp
technique (Fig. 5A–E). The cells were voltage-clamped at
280 mV and subsequently depolarized in steps of 20 mV every
s (Fig. 5A and B). After establishment of the whole-cell
configuration, current recordings showed a marked ‘run-down’.
To compensate for this ‘run-down’, whole-cell current was
measured before and after addition of the Kv1.1 blocker
dendrotoxin-K and the effect of the toxin was compared to the
estimated whole-cell current. In wild-type b-cells, the K
+ current
was decreased by 20 nmol/l dendrotoxin-K with 2065% (n=6;
P,0.01) and in mceph/mceph b-cells with 12611% (n=6, n.s.). No
significant difference could be monitored between the wild-type
and mceph/mceph b-cell whole cell currents. Compiled data of the
effect of dendrotoxin-K on normalized whole-cell K
+ currents in
wild-type and mecph/mceph beta cells are shown in Fig. 5E.
Membrane potentials. Membrane potentials were
monitored using the perforated-patch technique. The membrane
potential at 3 mmol/l glucose was 25864m V( n=4) in wild-type
b-cells, and increased to 24162m V( n=5) in the presence of
15 mmol/l glucose (measured as the lowest point between two
action potentials). Addition of 20 nmol/l dendrotoxin-K did not
affect membrane potential (23967 mV, n=3, n.s.). In mceph/
mceph b-cells, membrane potential was 25965m V( n=6) and
23264m V( n=3) in the presence of 3 mmol/l and 15 mmol/l
glucose, respectively. In the presence of 15 mmol/l glucose and
20 nmol/l dendrotoxin-K, the membrane potential was
23666m V( n=3, n.s). The mceph/mceph mice islets were thus
more depolarised in 15 vs. 3.3 mmol/l glucose compared to wild
type islets (23264 vs. 24162 mV), P=0.018.
Action potentials. The traces of membrane potential
recordings from wild-type (Fig. 6A) and mceph/mceph b-cells are
shown in Fig. 6B. On an expanded time scale (Fig. 6C–D) details
of action potential frequency can be monitored. The frequency of
action potentials in wild-type b-cells was significantly lower,
compared to that observed in mceph/mceph b-cells, whereas the
frequency of action potentials decreased in the presence of
dendrotoxin-K in wild-type b-cells but remained unaltered in
mceph/mceph b-cells (Fig. 6G).
Detailed analysis of action potential characteri-
zes. Fig. 6E–F show the summary of 20 action potentials
obtained in the presence of 15 mmol/l glucose 6 dendrotoxin-K.
In wild-type b-cells (Fig. 6E), addition of 20 nmol/l dendrotoxin-K
prolonged the repolarisation phase (ii and iv). This effect was
reversible upon wash-out of the toxin (iii). Augmentation of the
repolarization phase was not seen in mceph/mceph b-cells (Fig. 6F),
in which action potentials remained unaltered in the presence of
dendrotoxin-K (Fig. 6F, i–iii). Fig. 6H shows compiled data of the
repolarisation phase in wild-type and mceph/mceph b-cells,
measured as a time lag from the action potential peak and 2/3
of the action potential amplitude (Fig. 6I). The action potential
duration was significantly prolonged in b-cells from mceph/mceph
mice, compared to those from wild-type mice. Action potential
duration was also significantly increased in wild-type b-cells
treated with dendrotoxin-K, while dendrotoxin-K did not affect
the action potential duration in mceph/mceph b-cells.
Table 1. Age, weight and non-fasting blood glucose values in
wild-type, mceph/mceph and Kv1.1 null mice.
Age (days) Weight (g) Glucose (mmol/l) Animals (n)
Wild type 7763.5 2461.0 8.860.4 46
mceph/mceph 7462.5 1960.8
* 9.160.4 27
Kv1.1 null 7364.6 2161.0
* 7.160.6*
{ 18
*P,0.05 vs. wild type.
{P,0.05 vs. mceph/mceph.
All comparisons were made with One Way ANOVA, Student-Newman-Keuls
Method.
doi:10.1371/journal.pone.0018213.t001
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dendrotoxin-K is able to block a fraction of the total K
+ current
in wild-type b-cells, whereas this effect is not present in b-cells
from the mceph/mceph mouse. Detailed analyses of these action
potentials showed that mceph/mceph b-cells display a higher action
potential frequency and a prolongation of repolarization, com-
pared to wild-type b-cells. This effect on action potential duration
could be mimicked by dendrotoxin-K in wild-type b-cells.
Results in Kv1.1 null mice
With limited access to Kv1.1 null mice we tested for
confirmation of some of the findings in mceph/mceph. There were
no differences in islet structure in Kv1.1 null mice, compared to
wild-type and mceph/mceph (Fig. 3A). In perifusion experiments
with islets from wild-type and Kv1.1 null mice, in which the glucose
concentration was increased from 3.3 to 7 mmol/l, insulin
secretion was significantly increased in Kv1.1 null islets vs. wild-
type islets (0.4760.06 vs. 0.1960.05 mU/islets/min, n=3 and 4
experiments, P=0.037). The average insulin response from islets
when glucose levels rose from 3.3 to 16.7 mmol/l in perifusion
experiments was significantly elevated in both mceph/mceph and in
Kv1.1 null islets vs. wild type islets (Fig. 4E, F and G).
Also, the lack of effect of dendrotoxin-K in mceph/mcpeh islets
was confirmed in Kv1.1 null islets (Fig. 4F and G). Blood glucose
levels were significantly lower in Kv1.1 null animals compared to
wild type and mceph/mceph (Table 1). Plasma insulin levels
displayed a tendency towards higher insulin levels in the Kv1.1
null mice (3.4862.3 ng/ml, n=6) vs. wild type (1.8360.7 ng/ml,
n=8) and mceph/mceph (1.1860.9 ng/ml. n=6) mice. Patch clamp
recordings showed that in Kv1.1 null b-cells, the K
+ current was
non-significantly decreased by 20 nmol/l dendrotoxin-K with
10615% (n=6; n.s, Fig. 5E).
Discussion
We demonstrate the presence of Kv1.1-specific transcripts in
mouse, rat and human islets. Previous reports are discrepant as to
the expression of Kv1.1 in primary pancreatic b cells [1,20,21].
Discrepancies may be due to the sensitivity of the techniques used.
Here we examined Kv1.1 expression by an optimized PCR
methodology with appropriate negative controls in all cases.
Consistent Kv1.1 amplification from cDNA prepared from rodent
islets required 40 cycles of amplification from template levels
corresponding to 50 ng total RNA. This indicates that this gene is
expressed, albeit at low levels, in mouse and rat islets. Notably, in
human islets prepared from six individuals (three controls, three
diabetics), Kv1.1 expression was detectable in each sample at
template levels corresponding to 10 ng total RNA, and these
observations were confirmed by TaqMan real-time PCR and
cDNA microarray (data not shown). A previous study did not
detect Kv1.1 expression in human islets, however, in that study
islets from only a single individual were analyzed [22].
We found that pancreatic islets from mceph/mceph mice secrete
more insulin in response to glucose compared to islets from wild
type mice. The confirmation of these findings in Kv1.1 null mice
indicates that the increase in insulin secretion is indeed due to the
lack of functional Kv1.1 channels. The effects of the Kv1.1 blocker
dendrotoxin-K on insulin release also strongly indicate that an
enhanced insulin response to glucose in the mceph/mceph mice is
due to a lack of functional Kv1.1 activity. Thus, both in static
incubations (islets) and in perifusion experiments (islets and
dispersed islet cells), dendrotoxin-K augmented insulin secretion
from wild-type mice but not from mceph/mceph mice. Perifusion
experiments with islets from Kv1.1 null animals further confirmed
these findings.
Our experiments give further indications of the specific impact
of the Kv1.1 channel mutation on membrane electrophysiology of
b-cells from mceph/mceph mice. Importantly, glucose-induced
action potentials were increased in spiking frequency and duration
in mceph/mceph mice when measured in the absence of dendro-
toxin-K. The fact that mceph/mceph mice b-cells showed an
increased action potential frequency at the same time as the
action potential duration was increased may seem hard to
understand since one would expect a slower frequency (2). At
15 mmol/l glucose there was an increase in membrane potential
in mceph/mceph vs. wild type b-cells (23264 vs. 24162 mV,
P=0.018) which could at least in part explain this finding.
Increased action potential duration has also been observed in
ventricular myocytes from the hearts of Kv1DN mice with over-
expression of a truncated Kv1.1 [23]. Our results with
dendrotoxin-K were in further agreement with the Kv1.1 channel
being functional at the level of electrophysiology. Thus, in wild
type b-cells dendrotoxin-K obliterated the differences between
wild-type and the mceph/mceph mice regarding b-cell action
potential duration.
Our results concerning expression of the Kv1.1 mRNA and
protein support a key role for the Kv1.1 mutation in the abnormal
function of b-cells from mceph/mceph mice. Kv1.1 expression was
thus readily detected in wild-type islets, whereas a truncated form
was found in mceph/mceph islets. Interestingly, the Kv1.1 protein
seemed, in its truncated form in mceph/mceph islets, more abundant
than the normal protein in islets of wild-type mice. These
observations are similar to those reported for some regions in
the brain of mceph/mceph mice. Accumulation of truncated protein
could theoretically have untoward and toxic effects. However, we
note that there were, by histological analysis, no signs of b-cell
toxicity in mceph/mceph mice. Furthermore, there was no sign of
change in the expression of Kv2.1 protein. Ablation of Kv2.1 also
affected action potentials in a way that was not observed here [2].
Figure 4. Increased glucose-induced insulin secretion in islets from mceph/mceph vs. wild type mice. Glucose-induced insulin secretion
from batch-type incubations of islets of Langerhans from wild-type (+/+) and mceph/mceph (m/m) mice, n=11 (A). *P,0.03 vs. wild type.
Dendrotoxin-K increases insulin secretion in wild type but not in mceph/mceph and Kv1.1 null mouse islets. Incremental insulin release
from batch-type incubations of islets from wild-type (wt) and mceph/mceph (m/m) mice in response to 10 nmol/l dendrotoxin-K (dtx), n=7 (B). The
difference in response to dendrotoxin-K for wild-type and mceph/mceph mice was significant, *P=0.02 (C). Each batch-type experiment was
performed in triplicate or quadruplicate with three equal-sized islets per tube. Equal amounts of islets from wild-type (D, n=4), mutant mceph/mceph
(E, n=4) or Kv1.1 null (F, n=3) mice were loaded into separate perifusion chambers. For typographical reasons only every fifth error bar is shown in (E
and F). The response to 10 nmol/l dendrotoxin-K in wild-type islets was significant (*P=0.05). For details of how the dendrotoxin-K-effect was
calculated see results. (G) summarises average insulin response to glucose level elevation from 3.3 to 16.7 mmol/l as well as addition of dendrotoxin-
K in the islet perifusion experiments. (The insulin response to an increase in glucose concentration from 3.3 to 16.7 mmol/l was significantly increased
in islets from mceph/mceph and Kv1.1 null vs. wild-type mice (*P=0.01). The response to dendrotoxin-K in wild-type islets was significant ({P=0.05),
while that was not the case in mceph/mceph and Kv1.1 null islets. Increased insulin response to dendrotoxin-K and TEA in dispersed islet
cells from wild type mice. Perifusion with 200 nmol/l dendrotoxin-K or 15 mmol/l TEA. 0.5 mmol/l IBMX was present from min 5 to 51. One typical
experiment out of three is shown (H).
doi:10.1371/journal.pone.0018213.g004
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PLoS ONE | www.plosone.org 8 April 2011 | Volume 6 | Issue 4 | e18213Immunostaining showed that Kv1.1 was present also in a- and
d-cells. The functional role, if any, for Kv1.1 in these cells remains
to be investigated.
The significantly lower levels of blood glucose and the tendency
for higher serum insulin levels in Kv1.1 null mice vs. wild type seem
logical. In contrast mceph/mceph mice exhibit blood glucose and
insulin levels that are similar to those seen in wild-type mice.
mceph/mceph and Kv1.1 null mice have a similar behavioural
phenotype with body tremor, jittering and occasional forelimb
paddling, and cramps. However, the phenotype of mceph/mceph
mice appears more severe than that of the Kv1.1 null mice
(Lavebratt, unpublished observations). More marked severity of
Kv1.1 deficiency phenotype could lead to a higher stress level
which in turn could result in higher blood glucose levels and
increased insulin resistance. In vivo stress could also activate
alpha-adrenergic receptors on the b-cell and thereby inhibit
insulin secretion thus counteracting the increased insulin secretion
from islets when tested in vitro.
Another possibility is that lack of Kv1.1 in the CNS induces
problems of glucose sensing in the hypothalamus that could
secondarily affect the endocrine pancreas in different ways in the
mceph/mceph and Kv1.1 null mice. The truncated Kv1.1 in mceph/
Figure 5. Dendrotoxin-K significantly blocks relative K
+ currents in wild type vs. mceph/mceph b-cells. Whole-cell patch-clamp
recordings from wild-type and mceph/mceph pancreatic b-cells. I-V relationship for wild-type (A) and mceph/mceph (B) pancreatic b-cells before,
during and after exposure to 20 nmol/l dendrotoxin-K were obtained by clamping the cells at 280 mV and subsequently depolarized in steps of
20 mV for 100 ms to 80 mV. Example traces are recorded from wild-type b-cell in (C) at +80 mV, and the current measured at +80 mV is plotted every
20 s (D). In (E), to compensate for channel run-down, in each recording whole-cell K
+ current was normalized to the estimated K
+ current by
extrapolating the current before and after the toxin administration.*P,0.05; n.s., not significant.
doi:10.1371/journal.pone.0018213.g005
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PLoS ONE | www.plosone.org 9 April 2011 | Volume 6 | Issue 4 | e18213Figure 6. mceph/mceph b-cells display a higher action potential frequency and a prolongation of repolarization vs. wild-type b-cells.
Membrane potential were recorded in pancreatic b-cells isolated from wild-type mouse (A) and mceph/mceph mouse (B). (C) and (D), displays
recordings of membrane potential on an expanded time scale during 15 mmol/l glucose (i). (E) and (F) show summary of 20 action potentials at
15 mmol/glucose +/220 nmol/l dendrotoxin-K (indicated by roman numbers i, ii, iii and iv). (G), action potential frequency (per 60 s) in 15 mmol/l
glucose in b-cells isolated from wild-type (n=4) and mceph/mceph (n=6), with and without 20 nmol/l dendrotoxin-K (n=3, both groups). (H) shows
compiled data of repolarisation phase in wild-type and mceph/mceph b-cells, measured as time lag from action potential peak and 2/3 of action
potential amplitude (see schematic drawing in (I)). All analysis of action potential characteristics were performed using sections of membrane
potential recording in close proximity and prior to change of solution. *P,0.05; n.s., not significant.
doi:10.1371/journal.pone.0018213.g006
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PLoS ONE | www.plosone.org 10 April 2011 | Volume 6 | Issue 4 | e18213mceph mice can assemble with other Kv1 subunits and potentially
trap them in endoplasmatic reticulum with subsequent degrada-
tion [11].
Which importance should then be assigned to the Kv1.1
channel for b-cell function vis-a `-vis other Kv channels? A large
body of evidence indicates that the Kv2.1 channel is the major K
+-
rectifying channel in b-cells. Nevertheless, as highlighted by a
recent study [2] Kv2.1 is not the only Kv channel of importance.
Hence a supplementary role for Kv1.1 channel (as well as perhaps
other Kv channels) can be envisaged. Notably, our results indicate
that this notion can be extended also to human beta cells.
In summary Kv1.1 channels display an inter-species expression
pattern. Furthermore, our results in mouse b-cells indicate that
these channels are of functional importance.
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